153 related articles for article (PubMed ID: 1365661)
1. Attenuation of muscarinic receptor blockade-induced impairment of spatial delayed alternation performance by the triazole MDL 26,479.
Holley LA; Dudchenko P; Sarter M
Psychopharmacology (Berl); 1992; 109(1-2):223-30. PubMed ID: 1365661
[TBL] [Abstract][Full Text] [Related]
2. Enhancement of working memory performance in the rat by MDL 26,479, a novel compound with activity at the GABAA receptor complex.
Moran PM; Kane JM; Moser PC
Brain Res; 1992 Jan; 569(1):156-8. PubMed ID: 1319259
[TBL] [Abstract][Full Text] [Related]
3. Bidirectional modulation of scopolamine-induced working memory impairments by muscarinic activation of the medial septal area.
Givens B; Olton DS
Neurobiol Learn Mem; 1995 May; 63(3):269-76. PubMed ID: 7670840
[TBL] [Abstract][Full Text] [Related]
4. Behavioral microanalysis of spatial delayed alternation performance: rehearsal through overt behavior, and effects of scopolamine and chlordiazepoxide.
Dudchenko P; Sarter M
Psychopharmacology (Berl); 1992; 107(2-3):263-70. PubMed ID: 1615125
[TBL] [Abstract][Full Text] [Related]
5. Effects of MDL 73005 on water-maze performances and locomotor activity in scopolamine-treated rats.
Bertrand F; Lehmann O; Galani R; Lazarus C; Jeltsch H; Cassel JC
Pharmacol Biochem Behav; 2001 Apr; 68(4):647-60. PubMed ID: 11526961
[TBL] [Abstract][Full Text] [Related]
6. Dopaminergic involvement in the improving effects of dynorphin A-(1-13) on scopolamine-induced impairment of alternation performance.
Itoh J; Ukai M; Kameyama T
Eur J Pharmacol; 1993 Sep; 241(1):99-104. PubMed ID: 7901037
[TBL] [Abstract][Full Text] [Related]
7. Dissociation of cholinergic function in spatial and procedural learning in rats.
von Linstow Roloff E; Harbaran D; Micheau J; Platt B; Riedel G
Neuroscience; 2007 May; 146(3):875-89. PubMed ID: 17418958
[TBL] [Abstract][Full Text] [Related]
8. Effects of antiepileptic drugs on working memory as assessed by spatial alternation performance in rats.
Shannon HE; Love PL
Epilepsy Behav; 2004 Dec; 5(6):857-65. PubMed ID: 15582833
[TBL] [Abstract][Full Text] [Related]
9. Differential effects of scopolamine and mecamylamine on working and reference memory in the rat.
Moran PM
Pharmacol Biochem Behav; 1993 Jul; 45(3):533-8. PubMed ID: 8332613
[TBL] [Abstract][Full Text] [Related]
10. Endomorphin-1 improves scopolamine-induced impairment of short-term memory via mu1-opioid receptor in mice.
Ukai M; Katoh T; Mamiya T
Neuroreport; 2001 Dec; 12(17):3723-7. PubMed ID: 11726782
[TBL] [Abstract][Full Text] [Related]
11. Comparative behavioral and neurochemical activities of cholinergic antagonists in rats.
Bymaster FP; Heath I; Hendrix JC; Shannon HE
J Pharmacol Exp Ther; 1993 Oct; 267(1):16-24. PubMed ID: 7901390
[TBL] [Abstract][Full Text] [Related]
12. SCH 57790, a selective muscarinic M(2) receptor antagonist, releases acetylcholine and produces cognitive enhancement in laboratory animals.
Carey GJ; Billard W; Binch H; Cohen-Williams M; Crosby G; Grzelak M; Guzik H; Kozlowski JA; Lowe DB; Pond AJ; Tedesco RP; Watkins RW; Coffin VL
Eur J Pharmacol; 2001 Nov; 431(2):189-200. PubMed ID: 11728425
[TBL] [Abstract][Full Text] [Related]
13. Long-term clomipramine treatment upregulates forebrain acetylcholine muscarinic receptors, and reduces behavioural sensitivity to scopolamine in mice.
Tsukagoshi H; Morita T; Hitomi S; Saito S; Kadoi Y; Uchihashi Y; Kuribara H; Goto F
J Pharm Pharmacol; 2000 Jan; 52(1):87-92. PubMed ID: 10716608
[TBL] [Abstract][Full Text] [Related]
14. Role of central cholinergic receptor sub-types in spatial working memory: a five-arm maze task in mice provides evidence for a functional role of nicotinic receptors in mediating trace access processes.
Maviel T; Durkin TP
Neuroscience; 2003; 120(4):1049-59. PubMed ID: 12927210
[TBL] [Abstract][Full Text] [Related]
15. Effects of nicotine on memory impairment induced by blockade of muscarinic, nicotinic and dopamine D2 receptors in rats.
Hefco V; Yamada K; Hefco A; Hritcu L; Tiron A; Olariu A; Nabeshima T
Eur J Pharmacol; 2003 Aug; 474(2-3):227-32. PubMed ID: 12921867
[TBL] [Abstract][Full Text] [Related]
16. Nonhippocampal muscarinic receptors are required for nonspatial working memory.
Wan RQ; Pang K; Olton DS
Pharmacol Biochem Behav; 1997 Oct; 58(2):361-7. PubMed ID: 9300593
[TBL] [Abstract][Full Text] [Related]
17. Combined treatment with a 5HT1A receptor agonist and a muscarinic acetylcholine receptor antagonist disrupts water maze navigation behavior.
Riekkinen M; Sirviö J; Toivanen T; Riekkinen P
Psychopharmacology (Berl); 1995 Nov; 122(2):137-46. PubMed ID: 8848529
[TBL] [Abstract][Full Text] [Related]
18. Muscarinic and nicotinic receptor modulation of object and spatial n-back working memory in humans.
Green A; Ellis KA; Ellis J; Bartholomeusz CF; Ilic S; Croft RJ; Phan KL; Nathan PJ
Pharmacol Biochem Behav; 2005 Jul; 81(3):575-84. PubMed ID: 15936063
[TBL] [Abstract][Full Text] [Related]
19. Effects of rolipram on scopolamine-induced impairment of working and reference memory in the radial-arm maze tests in rats.
Zhang HT; O'Donnell JM
Psychopharmacology (Berl); 2000 Jun; 150(3):311-6. PubMed ID: 10923759
[TBL] [Abstract][Full Text] [Related]
20. Muscarinic and nicotinic receptors synergistically modulate working memory and attention in humans.
Ellis JR; Ellis KA; Bartholomeusz CF; Harrison BJ; Wesnes KA; Erskine FF; Vitetta L; Nathan PJ
Int J Neuropsychopharmacol; 2006 Apr; 9(2):175-89. PubMed ID: 15877932
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
